A metered-dose inhaler is being distributed by Novachem in Australia. Syqe® Medical, the Israeli MedTech company behind the technology claims it will “revolutionize” the delivery of medicinal cannabis.
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of the SyqeAir Metered-Dose Cannabis Inhaler for Chronic Neuropathic Pain: A Phase 1a Study
Syqe®’s first study (2014) examined whether metered and low doses of Δ9-THC allow for dose-dependent pain reduction of chronic neuropathic pain without significant adverse events. Listen to the podcast.